iGEN
Visit IGEN World Explore IGEN Expo
EXPLORE UPGRADE PLANS
BREAKING
Everyone Is Freaking Out About OpenAI and Anthropic’s Race for Dominance Govt Debunks AI-Generated Fake Video of Finance Minister Nirmala Sitharaman Promoting Investment Scheme UPS Unveils Digital Tools to Attract Small Businesses Amid Strategic Shift from Low-Margin E-Commerce CPKC sets second-quarter revenue record as operating income rises 10% Your Freight Funnel Is Leaking Margin: What Your Reports Won't Show Transponders Off: Saudi Crude Tankers for India Exit Red Sea 'Dark' to Avoid Houthi Blockade Nvidia’s Open Source Alliance Snubs OpenAI and Anthropic, Deepening AI Rift For the First Time, Zoox Can Charge People for Rides in Its Steering-Wheel-Free Robotaxis Chrome's AI-Driven Bug Hunt Spurs Twice-a-Week Security Patches, Google Reports Domestic Sugar Prices to Remain Firm in Short-Term, Says Triveni Engineering Everyone Is Freaking Out About OpenAI and Anthropic’s Race for Dominance Govt Debunks AI-Generated Fake Video of Finance Minister Nirmala Sitharaman Promoting Investment Scheme UPS Unveils Digital Tools to Attract Small Businesses Amid Strategic Shift from Low-Margin E-Commerce CPKC sets second-quarter revenue record as operating income rises 10% Your Freight Funnel Is Leaking Margin: What Your Reports Won't Show Transponders Off: Saudi Crude Tankers for India Exit Red Sea 'Dark' to Avoid Houthi Blockade Nvidia’s Open Source Alliance Snubs OpenAI and Anthropic, Deepening AI Rift For the First Time, Zoox Can Charge People for Rides in Its Steering-Wheel-Free Robotaxis Chrome's AI-Driven Bug Hunt Spurs Twice-a-Week Security Patches, Google Reports Domestic Sugar Prices to Remain Firm in Short-Term, Says Triveni Engineering
Home ›› Intl Trade ›› Import Export ›› Country Of Origin ›› Electronics, pharma and engineering goods lead India's FTA dividend as export engine shifts gears

Electronics, pharma and engineering goods lead India's FTA dividend as export engine shifts gears

Yes Securities has developed an FTA Opportunity Score to assess India's recent free trade agreements. Electronics emerged as the strongest sector with a score of 1.32, followed by pharmaceuticals at 0.66 and engineering goods at 0.50, with Monte Carlo simulations confirming positive outcomes for all three.

iG
iGEN Editorial
June 14, 2026
Electronics, pharma and engineering goods lead India's FTA dividend as export engine shifts gears

India's recent wave of free trade agreements (FTAs) represents a fundamental shift from cautious protectionism toward deeper global trade integration, according to a research report by Yes Securities. The report builds an FTA Opportunity Score combining five dimensions: change in sectoral export share, structural trade competitiveness, export momentum, manufacturing growth, profitability relative to exports, and FDI intensity. Monte Carlo tests ran over 2,000 iterations with varying weights to ensure robustness.

Electronics: The Strongest Bet

The electronics sector scored 1.32 on the composite index, with a mean Monte Carlo score of 1.04 and a 90% confidence interval of 0.48-1.59 that "remains entirely positive," Yes Securities stated. India's shift from import dependence to smartphone and component manufacturing, backed by the Production Linked Incentive (PLI) scheme and Apple's supplier network, is converging with global supply-chain realignment. "Historically, Indian electronics exporters faced tariff disadvantages... India's FTAs with key developed nations like the UK, EU and US will substantially narrow this gap," the report said. Revealed Comparative Advantage (RCA) at 0.39 remains below China and Vietnam, but the trajectory is positive as localization deepens into PCBs, battery systems, and semiconductor packaging.

Engineering & Machinery: Tariff Sensitivity

Engineering and machinery goods scored 0.50 with a Monte Carlo mean of 0.53 and a 90% CI of 0.15-0.93, with only a 3.9% chance of negative outcomes. "Engineering goods are particularly sensitive to tariff reductions because they compete heavily on price, reliability, scale and supply-chain efficiency," Yes Securities noted. The sector's RCA improved from 0.23 in 2021 to 0.33 in 2025. FTAs with UAE, Australia, UK, EFTA, and EU can reduce tariff frictions in industrial markets. Exposure to infrastructure, renewables, and automation provides diversified, long-term demand.

Pharmaceuticals: Non-Tariff Gains Dominate

Pharmaceuticals, already highly specialized with an RCA of 1.5-2.0, posted an FTA score of 0.66 and a Monte Carlo mean of 0.86, CI 0.46-1.24 with virtually no downside. "FTAs with the UK, EU and US have the potential to improve regulatory cooperation, streamline certification processes, facilitate market access," Yes Securities said. Non-tariff gains matter more than tariff reductions for this sector.

Comparative Scores at a Glance

Sector FTA Score Monte Carlo Mean 90% CI Lower 90% CI Upper Downside Risk
Electronics 1.32 1.04 0.48 1.59 0%
Pharmaceuticals 0.66 0.86 0.46 1.24 ~0%
Engineering & Machinery 0.50 0.53 0.15 0.93 3.9%

For importers and exporters, these findings underscore the strategic importance of aligning supply chains with FTA-covered markets. Electronics components and engineering goods stand to gain from tariff reductions in developed economies, while pharmaceutical firms should prioritize regulatory harmonization under new trade pacts. Trade policy professionals can use the FTA Opportunity Score framework to identify sectors with the highest export dividend potential as India deepens its integration with global markets.


Sources: Economic Times – Foreign Trade

Keep Reading

Recommended Stories

NITI Aayog Proposes Pharma Chapter in Future FTAs, Urges India to Move Up Value Chain Trade

NITI Aayog Proposes Pharma Chapter in Future FTAs, Urges India to Move Up Value Chain

NITI Aayog’s eighth Trade Watch Quarterly report proposes a dedicated pharmaceuticals chapter in future free trade agreements to help India move up the value chain. The report calls for greater regulatory transparency, stronger industry-academia tech transfer, and shared environmental compliance infrastructure. It highlights India's 65% dependence on China for critical APIs and notes India supplies 50% of Africa's, 40% of the US', and 25% of the UK's generic drug needs.

July 8, 2026
Goyal meets exporters to discuss ways to boost shipments, leverage FTAs Trade

Goyal meets exporters to discuss ways to boost shipments, leverage FTAs

Piyush Goyal met with Export Promotion Councils and industry associations to discuss strategies for boosting exports and leveraging free trade agreements. The meeting focused on MSME support, innovation, and export facilitation. Trade data for April-May 2026-27 showed exports of USD 88.91 billion and imports of USD 145.35 billion.

June 25, 2026
Trump's Generic Drug Tariffs Explained: What It Means for Indian Pharma Before the 200% Storm Trade

Trump's Generic Drug Tariffs Explained: What It Means for Indian Pharma Before the 200% Storm

US President Donald Trump unveiled a phased tariff plan for imported generic medicines: duty-free for two years from August 1, then 100% for one year, followed by 200%. For Indian drugmakers, the plan offers temporary relief but signals a long-term shift. India's pharma exports to the US account for 34% of total pharma exports, worth $30.47 billion in 2024-25. Leading companies with US manufacturing operations may have greater flexibility.

July 22, 2026
Textile sector to sew loose ends as FTAs kick in Trade

Textile sector to sew loose ends as FTAs kick in

The operationalisation of the UK-India free trade agreement eliminates tariffs up to 12% on textile exports, bringing parity with competitors. Industry body Indian Texpreneurs Federation expects exports to double to a 12% share in 4-5 years, but experts caution about structural challenges.

July 17, 2026